Keywords: c-met; Synthesis; 4-Phenoxypyridine derivatives; 1,8-Naphthyridinone; Antiproliferative activity; c-Met; Flt-3;
مقالات ISI c-met (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: c-met; ADAM; a disintegrin and metalloproteinase; AKT; protein kinase B; APAF 1; apoptotic protease activating factor 1; APC; adenomatous polyposis coli; ATG; autophagy protein; BAK; Bcl 2 homologous antagonist/killer; BAX; Bcl-2 associated -X protein; Bcl-2; B-
Keywords: c-met; Ovarian cancer; EGFR; HER-2; c-MET; 3D cell culture; Targeted inhibitors; Ascites;
Keywords: c-met; ALK1; activin receptor-like kinase1; ANG/Ang; angiopoietin; Bcl-xL; b-cell lymphoma-extra large; BM; bone marrow; BMDCs; bone marrow derived cells; BMP; bone morphogenetic protein; Bv8; bombina variagata peptide 8; CAFs; cancer/carcinoma associated fibrob
Keywords: c-met; Dual EGFR/HER2 inhibitors; Resistance; T790M/L858R mutant EGFR; Irreversible inhibitors; ADMET; Absorption/Distribution/Metabolism/Excretion/Toxicity; Cbl; Casitas B-lineage Lymphoma; c-MET; cellular mesenchymal to epithelial transition factor; DM; double
Keywords: c-met; Pheochromocytomas; Paragangliomas; MERTK; MET; c-MET; H3F3A; FGFR1; Exome;
Keywords: c-met; Antimigratory; Antiproliferative; Anti-invasive; Breast cancer; c-Met; Olive secoiridoids; Homovanillyl sinapate; c-Met; mesenchymal-epithelial transition factor; SAR; structure-activity relationship; RTK; receptor tyrosine kinase; RON; recepteur d'origin
Keywords: c-met; Hepatocyte growth factor (HGF); C-Met; Prostate cancer; Rabbit monoclonal antibody;
Keywords: c-met; DNA damage response; Cell cycle regulation; PI3K/mTOR; NOTCH; c-MET; FGFR; Axl; Angiogenesis;
Keywords: c-met; Glioblastoma; Treatment; Review; Pharmacology; Targeted therapy; Stem cell; AKT; protein kinase B; BBB; blood-brain barrier; BCNU; carmustin; CCNU; lomustin; c-MET; hepatocyte growth factor receptor; EGF(R); epidermal growth factor (receptor); EGFRvIII; e
Keywords: c-met; HGF; c-Met; Inflammation; Autoimmunity; Autoimmune regulator; Therapy;
Keywords: c-met; Pancreatic cancer stem cell; CD44; c-Met; cabozantinib; Stemness; Metastases
Keywords: c-met; c-Met; Endosome; Signalling; Cell migration; Cancer
Keywords: c-met; Cornea; Diabetes; Limbal gene therapy; C-met; Cathepsin F; MMP-10; Stem cell marker; Signaling pathways;
Keywords: c-met; Gastric cancer; Esophageal cancer; Targeted therapy; HER2; EGFR; VEGFR; mTOR; c-MET
Keywords: c-met; Head and neck cancer; Squamous cell carcinoma; Predictive biomarkers; c-MET; YAP-1; Radio-resistance;
Keywords: c-met; c-Met; 4-Phenoxyquinoline derivatives; Anticancer activity; 2,4-Imidazolinedione/pyrazolone
Keywords: c-met; HGF; c-Met; PCOS; quality of oocyte; quality of embryo;
Keywords: c-met; c-Met; Kinase inhibitor; Anti-tumor; Quinoline; Semicarbazone;
Keywords: c-met; 5-hmC; 5-hydroxymethylcytosine; 5-mC; 5-methylcytosine; ADAM23; ADAM metallopeptidase domain 23; ADAMTS9; ADAM metallopeptidase with thrombospondin type 1 motif, 9; ARID1A; AT rich interactive domain 1A (SWI-like); AML; Acute myelocytic leukemia; ATBF1; A
Keywords: c-met; c-Met; Synthesis; Antiproliferative activity
c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival
Keywords: c-met; c-MET; Colorectal cancer; Immunohistochemistry; Prognosis;
Molecular dynamics guided development of indole based dual inhibitors of EGFR (T790M) and c-MET
Keywords: c-met; Indole-pyrimidine; Molecular dynamic simulations; EGFR (T790M); c-MET;
MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway
Keywords: c-met; MiR-206; c-Met; AKT/mTOR; Epithelial ovarian cancer; MicroRNA profiling;
MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway
Keywords: c-met; Hepatocellular carcinoma; miR-449a; c-Met; Proteomics; Tumorigenesis;
Chemopreventive and antitumor effects of benzyl isothiocynate on HCC models: A possible role of HGF /pAkt/ STAT3 axis and VEGF
Keywords: c-met; ALT; alanine amine transferase; AST; aspartate amino transferase; AFP; alpha fetoprotein; BITC; benzyl isothiocyanate; c-MET; mesenchymal-epithelial transition factor; DEN; diethylnitrosamine; DMEM; Dulbecco's modified Eagle's medium; DMSO; dimethylsulfox
Discovery of thinopyrimidine-triazole conjugates as c-Met targeting and apoptosis inducing agents
Keywords: c-met; N-methylpicolinamide; Thienopyrimidine; Triazole; c-Met; Antitumor activity; Docking study; Apoptosis;
Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program
Keywords: c-met; c-Met; Metastatic renal cell carcinoma; METEOR study; Targeted therapy; VEGF inhibitor;
Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer
Keywords: c-met; c-MET; Colorectal cancer (CRC); Hepatocyte growth factor; Maximum tolerated dose; SAIT301;
Scaffold hopping identifies 6,8-disubstituted purines as novel anaplastic lymphoma kinase inhibitors
Keywords: c-met; ALK; anaplastic lymphoma kinase; cMet; hepatocyte growth factor receptor; DIPEA; N,N-Diisopropylethylamine; DMF; N,N-Dimethylformamide; EML4; echinoderm microtubule-associated protein-like 4; FDA; food and drug administration; gk; gatekeeper; μW; micro w
Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity
Keywords: c-met; [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole; Synthesis; c-Met; Inhibitors; SAR;
Long noncoding RNA lncHand2 promotes liver repopulation via c-Met signaling
Keywords: c-met; LncHand2; Liver repopulation; Ino80 complex; Nkx1-2; c-Met;
Discovery, optimization and biological evaluation for novel c-Met kinase inhibitors
Keywords: c-met; c-Met; Virtual screening; Pharmacophore; X-ray crystallography; Structural optimization;
ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via c-MET/Fyn/β-catenin signaling pathway
Keywords: c-met; ISG15; interferon-stimulated gene 15; ESCC; esophageal squamous cell carcinoma; c-MET; mesenchymal-epithelial transition factor; Esophageal squamous cell carcinoma; Interferon-stimulated gene 15; C-MET/Fyn/β-catenin pathway; Tumorigenesis;
Synthesis and bioevaluation study of novel N-methylpicolinamide and thienopyrimidine derivatives as selectivity c-Met kinase inhibitors
Keywords: c-met; N-Methylpicolinamide; Thienopyrimidine; Pyridazinone; c-Met; Bioevaluation;
Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals
Keywords: c-met; Bladder cancer; Estrogen receptor; c-MET; Tumor microenvironment;
Hsa-microRNA-101-3p expression in human urinary bladder cancer: Correlation with tumor pathology
Keywords: c-met; BC; Bladder cancer; Bcl-2; B cell lymphoma-2; BTCC; Bladder transitional cell carcinoma; c-Met; Tyrosine-protein kinase Met; EZH2; Enhancer of zeste homologue 2; FGFR3; Fibroblast growth factor receptor 3; Hsa-microRNA-101-3p; Homosapiens micro RNA-101 st
Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety
Keywords: c-met; Synthesis; Pyrrolo[2,3-b]pyridine derivatives; 1,8-Naphthyridin-2-one; Antiproliferative activity; c-Met; Flt-3;
Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis
Keywords: c-met; Prostate cancer; Bone metastasis; Osteoblasts; c-Met; VEGFR2;
Fishing wild-type sparing inhibitors of proto-oncogene c-met variants in renal cell carcinoma from a curated tyrosine kinase inhibitor pool using analog-sensitive kinase technology
Keywords: c-met; Renal cell carcinoma; c-Met; Tyrosine kinase inhibitor; Selectivity; Missense mutation; Inhibitor response-to-kinase mutation profile;
miR-146a targets c-met and abolishes colorectal cancer liver metastasis
Keywords: c-met; miR-146a; c-met; Colorectal cancer; Liver metastasis;
Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 1,8-naphthyridin-2-one moiety
Keywords: c-met; Synthesis; Quinoline derivatives; Antiproliferative activity; c-Met;
Prognostic Factors in Skull Base Chordoma: A Systematic Literature Review and Meta-Analysis
Keywords: c-met; Meta-analysis; Prognosis; Prognostic factors; Skull base chordoma; Survival; CI; Confidence interval; c-Met; Hepatocyte growth factor receptor; EGFR; Epidermal growth factor receptor; HR; Hazard ratio; hTERT; Human telomerase reverse transcriptase; IR; In
Design, synthesis, and biological evaluation of thieno[2,3-d]pyrimidine derivatives as novel dual c-Met and VEGFR-2 kinase inhibitors
Keywords: c-met; c-Met; VEGFR-2; Kinase; Thieno[2,3-d]pyrimidine; Cancer;
Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway
Keywords: c-met; Salvianolic acid A; Cisplatin resistance; Lung cancer; c-Met; Reversal mechanism;
Discovery of novel 2-substituted-4-(2-fluorophenoxy) pyridine derivatives possessing pyrazolone and triazole moieties as dual c-Met/VEGFR-2 receptor tyrosine kinase inhibitors
Keywords: c-met; c-Met; VEGFR-2; 2-Substituted-4-(2-fluorophenoxy) pyridine; Pyrazolone; Triazole;
Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer
Keywords: c-met; Advanced NSCLC; c-Met; Immunohistochemistry; Prognosis; Soluble c-Met;
Short CommunicaitonTumor regression grades, K-RAS mutational profile and c-MET in colorectal liver metastases
Keywords: c-met; Colorectal cancer; Liver metastasis; K-RAS; C-MET;
Original contributionThe gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma
Keywords: c-met; Ovarian carcinoma; c-MET; In situ hybridization; Survival; Gene copy number;
Co-targeting c-Met and DNA double-strand breaks (DSBs): Therapeutic strategies in BRCA-mutated gastric carcinomas
Keywords: c-met; Gastric cancer; Hepatocyte growth factor receptor; c-MET; BRCA proteins; HR;